Q4 2025 Holdings
Filed 2026-02-12 | 36 holdings | $438.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $40.2M | 745,955 | 9.2% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $38.3M | 363,651 | 8.7% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $25.9M | 269,644 | 5.9% |
| Becton Dickinson & Co(BDX) | COM | 075887109 | $25.7M | 132,376 | 5.9% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $21.7M | 176,414 | 4.9% |
| Incyte Corp(INCY) | COM | 45337C102 | $21.6M | 218,783 | 4.9% |
| Pfizer Inc(PFE) | COM | 717081103 | $21.4M | 859,539 | 4.9% |
| Amgen Inc(AMGN) | COM | 031162100 | $20.0M | 60,956 | 4.5% |
| Biogen Inc(BIIB) | COM | 09062X103 | $15.0M | 85,475 | 3.4% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $14.6M | 184,977 | 3.3% |
| CVS Health Corp(CVS) | COM | 126650100 | $14.1M | 177,599 | 3.2% |
| Cardinal Health Inc(CAH) | COM | 14149Y108 | $12.7M | 61,946 | 2.9% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $12.6M | 21,688 | 2.9% |
| Bruker Corp(BRKR) | COM | 116794108 | $12.0M | 254,697 | 2.7% |
| Zimmer Biomet Holdings Inc(ZBH) | COM | 98956P102 | $11.9M | 132,478 | 2.7% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $11.8M | 198,505 | 2.7% |
| Elevance Health Inc Formerly(ELV) | COM | 036752103 | $11.4M | 32,546 | 2.6% |
| Centene Corp del(CNC) | COM | 15135B101 | $10.6M | 258,109 | 2.4% |
| GE Healthcare Technologies I(GEHC) | COMMON STOCK | 36266G107 | $9.4M | 114,390 | 2.1% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $8.2M | 96,402 | 1.9% |
| Avantor Inc(AVTR) | COM | 05352A100 | $8.0M | 695,403 | 1.8% |
| BIO RAD Labs Inc(BIO) | CL A | 090572207 | $7.2M | 23,750 | 1.6% |
| Labcorp Holdings Inc(LH) | COM SHS | 504922105 | $6.8M | 27,019 | 1.5% |
| Lantheus Hldgs Inc(LNTH) | COM | 516544103 | $6.2M | 93,823 | 1.4% |
| Tandem Diabetes Care Inc(TNDM) | COM NEW | 875372203 | $5.9M | 267,091 | 1.3% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $5.5M | 7,165 | 1.3% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $5.4M | 115,000 | 1.2% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $5.3M | 252,062 | 1.2% |
| Dexcom Inc(DXCM) | COM | 252131107 | $5.1M | 76,122 | 1.2% |
| HCA Healthcare Inc(HCA) | COM | 40412C101 | $5.0M | 10,784 | 1.1% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $4.7M | 455,841 | 1.1% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $4.7M | 61,923 | 1.1% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $3.5M | 16,305 | 0.8% |
| CG Oncology Inc(CGON) | COM | 156944100 | $2.2M | 52,039 | 0.5% |
| Organon & Co(OGN) | COMMON STOCK | 68622V106 | $2.2M | 300,000 | 0.5% |
| Certara Inc(CERT) | COM | 15687V109 | $2.0M | 230,565 | 0.5% |